drugset / Trial / NCT06845852

A Phase 1 Mass Balance Study of Varegacestat

NCT06845852 ↗

Phase 1 Completed 6 enrolled Immunome, Inc.
NaSingle-groupOpen-labelOther

Summary

This clinical study is designed to study the mass balance of a single dose of varegacestat in healthy male participants.

Timeline

Start
2025-02-25
Primary completion
2025-03-11
Completion
2025-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject varegacestat Small molecule — Oral

Indications

No indication recorded.